SAFB2 Enables the Processing of Suboptimal Stem-Loop Structures in Clustered Primary miRNA Transcripts.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
04 06 2020
Historique:
received: 02 12 2019
revised: 24 03 2020
accepted: 08 05 2020
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 20 9 2020
Statut: ppublish

Résumé

Many microRNAs (miRNAs) are generated from primary transcripts containing multiple clustered stem-loop structures that are thought to be recognized and cleaved by the Microprocessor complex as independent units. Here, we uncover an unexpected mode of processing of the bicistronic miR-15a-16-1 cluster. We find that the primary miR-15a stem-loop is not processed on its own but that the presence of the neighboring primary miR-16-1 stem-loop on the same transcript can compensate for this deficiency in cis. Using a CRISPR/Cas9 screen, we identify SAFB2 (scaffold attachment factor B2) as an essential co-factor in this miR-16-1-assisted pri-miR-15 cleavage and describe SAFB2 as an accessory protein of the Microprocessor. Notably, SAFB2-mediated cleavage expands to other clustered pri-miRNAs, indicating a general mechanism. Together, our study reveals an unrecognized function of SAFB2 in miRNA processing and suggests a scenario in which SAFB2 enables the binding and processing of suboptimal Microprocessor substrates in clustered primary miRNA transcripts.

Identifiants

pubmed: 32502422
pii: S1097-2765(20)30312-9
doi: 10.1016/j.molcel.2020.05.011
pii:
doi:

Substances chimiques

MIRN15 microRNA, human 0
MIRN16 microRNA, human 0
Matrix Attachment Region Binding Proteins 0
MicroRNAs 0
Nuclear Matrix-Associated Proteins 0
RNA-Binding Proteins 0
Receptors, Estrogen 0
SAFB2 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

876-889.e6

Subventions

Organisme : Austrian Science Fund FWF
ID : P 30194
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 30196
Pays : Austria

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Katharina Hutter (K)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Michael Lohmüller (M)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Almina Jukic (A)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Felix Eichin (F)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Seymen Avci (S)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Verena Labi (V)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Tamas G Szabo (TG)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Simon M Hoser (SM)

Institute for Genomics and RNomics, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Alexander Hüttenhofer (A)

Institute for Genomics and RNomics, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Andreas Villunger (A)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, 1090 Vienna, Austria.

Sebastian Herzog (S)

Institute of Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria. Electronic address: sebastian.herzog@i-med.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH